TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomised Feasibility Study of Optimal Transfusion Thresholds in Anaemic Cancer Patients Treated With Chemotherapy (HaemOPtimal)
Brief Summary: This an open two-arm interventional randomised feasibility study in anaemic patients treated with chemotherapy. Randomisation is performed between two transfusion thresholds: Haemoglobin \< 6.0 mmol/l (9.9 g/dL) versus haemoglobin \< 7.1 mmol/l (11.7 g/dL) for female and 8.1 mmol/l (13.4 g/dL) for males.Primary end-point is quality of life


Options:
A: Arm Label: Blood transfusion; Type: EXPERIMENTAL; Interventions: Biological: Blood transfusion | Intervention Type: BIOLOGICAL; Name: Blood transfusion; Assigned to Arm(s): Blood transfusion
B: Arm Label: "liberal" transfusion triggers; Type: EXPERIMENTAL; Interventions: Other: red blood cell transfusion | Arm Label: "restrictive" transfusion triggers; Type: ACTIVE_COMPARATOR; Interventions: Other: red blood cell transfusion | Intervention Type: OTHER; Name: red blood cell transfusion; Assigned to Arm(s): "liberal" transfusion triggers | Intervention Type: OTHER; Name: red blood cell transfusion; Assigned to Arm(s): "restrictive" transfusion triggers
C: Arm Label: Haemoglobin (<6.0 mmol/l); Type: ACTIVE_COMPARATOR; Interventions: Other: Blood transfusion | Arm Label: Haemoglobin (< normal range); Type: EXPERIMENTAL; Interventions: Other: Blood transfusion | Intervention Type: OTHER; Name: Blood transfusion; Assigned to Arm(s): Haemoglobin (< normal range), Haemoglobin (<6.0 mmol/l)
D: Arm Label: Restrictive Transfusion Strategy; Type: EXPERIMENTAL; Interventions: Procedure: Transfusion | Arm Label: Liberal Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Transfusion | Intervention Type: PROCEDURE; Name: Transfusion; Assigned to Arm(s): Liberal Transfusion Strategy, Restrictive Transfusion Strategy

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomised Feasibility Study of Optimal Transfusion Thresholds in Anaemic Cancer Patients Treated With Chemotherapy (HaemOPtimal)
Brief Summary: This an open two-arm interventional randomised feasibility study in anaemic patients treated with chemotherapy. Randomisation is performed between two transfusion thresholds: Haemoglobin \< 6.0 mmol/l (9.9 g/dL) versus haemoglobin \< 7.1 mmol/l (11.7 g/dL) for female and 8.1 mmol/l (13.4 g/dL) for males.Primary end-point is quality of life


Options:
A: Arm Label: Liberal blood transfusion; Type: ACTIVE_COMPARATOR; Interventions: Biological: SAGM (Saline-Adenine-Glucose-Mannitol) blood transfusion | Arm Label: Restrictive blood transfusion; Type: ACTIVE_COMPARATOR; Interventions: Biological: SAGM (Saline-Adenine-Glucose-Mannitol) blood transfusion | Intervention Type: BIOLOGICAL; Name: SAGM (Saline-Adenine-Glucose-Mannitol) blood transfusion; Assigned to Arm(s): Liberal blood transfusion | Intervention Type: BIOLOGICAL; Name: SAGM (Saline-Adenine-Glucose-Mannitol) blood transfusion; Assigned to Arm(s): Restrictive blood transfusion
B: Arm Label: Restrictive; Type: ACTIVE_COMPARATOR; Interventions: Biological: Administration of Red Cell | Arm Label: Liberal; Type: ACTIVE_COMPARATOR; Interventions: Biological: Administration of Red Cell | Intervention Type: BIOLOGICAL; Name: Administration of Red Cell; Assigned to Arm(s): Liberal, Restrictive
C: Arm Label: Restrictive Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Restrictive Transfusion Strategy | Arm Label: Liberal Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Liberal transfusion strategy | Intervention Type: OTHER; Name: Restrictive Transfusion Strategy; Assigned to Arm(s): Restrictive Transfusion Strategy | Intervention Type: OTHER; Name: Liberal transfusion strategy; Assigned to Arm(s): Liberal Transfusion Strategy
D: Arm Label: Haemoglobin (<6.0 mmol/l); Type: ACTIVE_COMPARATOR; Interventions: Other: Blood transfusion | Arm Label: Haemoglobin (< normal range); Type: EXPERIMENTAL; Interventions: Other: Blood transfusion | Intervention Type: OTHER; Name: Blood transfusion; Assigned to Arm(s): Haemoglobin (< normal range), Haemoglobin (<6.0 mmol/l)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomised Feasibility Study of Optimal Transfusion Thresholds in Anaemic Cancer Patients Treated With Chemotherapy (HaemOPtimal)
Brief Summary: This an open two-arm interventional randomised feasibility study in anaemic patients treated with chemotherapy. Randomisation is performed between two transfusion thresholds: Haemoglobin \< 6.0 mmol/l (9.9 g/dL) versus haemoglobin \< 7.1 mmol/l (11.7 g/dL) for female and 8.1 mmol/l (13.4 g/dL) for males.Primary end-point is quality of life


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Packed Red Blood Cell Transfusion | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Packed Red Blood Cell Transfusion | Intervention Type: PROCEDURE; Name: Packed Red Blood Cell Transfusion; Assigned to Arm(s): 1, 2
B: Arm Label: Liberal RBC Transfusion Strategy; Type: EXPERIMENTAL; Interventions: Other: Liberal RBC Transfusion Strategy | Arm Label: Restrictive RBC Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Restrictive RBC Transfusion Strategy | Intervention Type: OTHER; Name: Liberal RBC Transfusion Strategy; Assigned to Arm(s): Liberal RBC Transfusion Strategy | Intervention Type: OTHER; Name: Restrictive RBC Transfusion Strategy; Assigned to Arm(s): Restrictive RBC Transfusion Strategy
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Transfusion with Red Blood Cells, Biological: 1 unit of donated red blood cells | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Biological: 1 unit of donated red blood cells | Intervention Type: PROCEDURE; Name: Transfusion with Red Blood Cells; Assigned to Arm(s): 1 | Intervention Type: BIOLOGICAL; Name: 1 unit of donated red blood cells; Assigned to Arm(s): 1 | Intervention Type: BIOLOGICAL; Name: 1 unit of donated red blood cells; Assigned to Arm(s): 2
D: Arm Label: Haemoglobin (<6.0 mmol/l); Type: ACTIVE_COMPARATOR; Interventions: Other: Blood transfusion | Arm Label: Haemoglobin (< normal range); Type: EXPERIMENTAL; Interventions: Other: Blood transfusion | Intervention Type: OTHER; Name: Blood transfusion; Assigned to Arm(s): Haemoglobin (< normal range), Haemoglobin (<6.0 mmol/l)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Treatment of Screen-detected Celiac Disease in Adults
Brief Summary: The main purpose of this study is to evaluate the natural history of celiac disease in asymptomatic, screen-detected subjects having positive endomysial antibodies and the effects of an intervention with a gluten-free diet. The investigators hypothesize that these subjects may have decreased general health and benefit of the dietary treatment regardless of the small-bowel mucosal structure.


Options:
A: Intervention Type: OTHER; Name: Patients recruitment; Assigned to Arm(s): N/A
B: Arm Label: A - gluten challenge group; Type: EXPERIMENTAL; Interventions: Other: Gluten challenge | Arm Label: B - gluten-free diet; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Gluten challenge; Assigned to Arm(s): A - gluten challenge group
C: Arm Label: PRO-GFD; Type: EXPERIMENTAL; Interventions: Combination Product: Probiotic supplementation + gluten-free diet | Arm Label: PLA-GFD; Type: PLACEBO_COMPARATOR; Interventions: Combination Product: Placebo supplementation + gluten-free diet | Arm Label: PRO-GD; Type: EXPERIMENTAL; Interventions: Combination Product: Probiotic supplementation + gluten-containing diet | Arm Label: PLA-GD; Type: PLACEBO_COMPARATOR; Interventions: Combination Product: Placebo supplementation + gluten-containing diet | Intervention Type: COMBINATION_PRODUCT; Name: Probiotic supplementation + gluten-free diet; Assigned to Arm(s): PRO-GFD | Intervention Type: COMBINATION_PRODUCT; Name: Placebo supplementation + gluten-free diet; Assigned to Arm(s): PLA-GFD | Intervention Type: COMBINATION_PRODUCT; Name: Probiotic supplementation + gluten-containing diet; Assigned to Arm(s): PRO-GD | Intervention Type: COMBINATION_PRODUCT; Name: Placebo supplementation + gluten-containing diet; Assigned to Arm(s): PLA-GD
D: Arm Label: gluten-containing diet; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Active comparator, gluten-free diet; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Gluten-free diet | Intervention Type: DIETARY_SUPPLEMENT; Name: Gluten-free diet; Assigned to Arm(s): Active comparator, gluten-free diet

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Promoting Behavioral Change for Oral Health in American Indian Mothers and Children
Brief Summary: A program of motivational interviewing plus enhanced community services in prevention of early childhood caries vs. enhanced community services alone for American Indian mothers and their children will reduce the childrens' decayed, missing, and filled tooth surfaces measure over a 3-year period.


Options:
A: Arm Label: Little Holy One intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Newly created cultural components, adapted Family Spirit lessons, adapted CETA modules | Arm Label: Nutrition control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active nutrition control | Intervention Type: BEHAVIORAL; Name: Newly created cultural components, adapted Family Spirit lessons, adapted CETA modules; Assigned to Arm(s): Little Holy One intervention | Intervention Type: BEHAVIORAL; Name: Active nutrition control; Assigned to Arm(s): Nutrition control
B: Arm Label: Motivational interviewing and enhanced community services; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational interviewing, Behavioral: Enhanced community services | Arm Label: Enhanced community services; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced community services | Intervention Type: BEHAVIORAL; Name: Motivational interviewing; Assigned to Arm(s): Motivational interviewing and enhanced community services | Intervention Type: BEHAVIORAL; Name: Enhanced community services; Assigned to Arm(s): Enhanced community services, Motivational interviewing and enhanced community services
C: Arm Label: Healthy Children, Strong Families (first); Type: EXPERIMENTAL; Interventions: Behavioral: Healthy Children, Strong Families, Behavioral: Child Safety | Arm Label: Child Safety (first); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Healthy Children, Strong Families, Behavioral: Child Safety | Intervention Type: BEHAVIORAL; Name: Healthy Children, Strong Families; Assigned to Arm(s): Child Safety (first), Healthy Children, Strong Families (first) | Intervention Type: BEHAVIORAL; Name: Child Safety; Assigned to Arm(s): Child Safety (first), Healthy Children, Strong Families (first)
D: Arm Label: Family Spirit Intervention; Type: EXPERIMENTAL; Interventions: Procedure: Family Spirit Intervention | Arm Label: Optimized Standard Care Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Family Spirit Intervention; Assigned to Arm(s): Family Spirit Intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Promoting Behavioral Change for Oral Health in American Indian Mothers and Children
Brief Summary: A program of motivational interviewing plus enhanced community services in prevention of early childhood caries vs. enhanced community services alone for American Indian mothers and their children will reduce the childrens' decayed, missing, and filled tooth surfaces measure over a 3-year period.


Options:
A: Arm Label: + ind. CHO; Type: EXPERIMENTAL; Interventions: Other: High levels of indigestible carbohydrates | Arm Label: - ind. CHO; Type: EXPERIMENTAL; Interventions: Other: Low levels of indigestible carbohydrates | Intervention Type: OTHER; Name: High levels of indigestible carbohydrates; Assigned to Arm(s): + ind. CHO | Intervention Type: OTHER; Name: Low levels of indigestible carbohydrates; Assigned to Arm(s): - ind. CHO
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary Advice | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dietary Advice; Assigned to Arm(s): Intervention
C: Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: intervention; Type: EXPERIMENTAL; Interventions: Other: Improving nutrition knowledge among mothers | Intervention Type: OTHER; Name: Improving nutrition knowledge among mothers; Assigned to Arm(s): intervention
D: Arm Label: Motivational interviewing and enhanced community services; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational interviewing, Behavioral: Enhanced community services | Arm Label: Enhanced community services; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced community services | Intervention Type: BEHAVIORAL; Name: Motivational interviewing; Assigned to Arm(s): Motivational interviewing and enhanced community services | Intervention Type: BEHAVIORAL; Name: Enhanced community services; Assigned to Arm(s): Enhanced community services, Motivational interviewing and enhanced community services

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Preventing Caries in Preschoolers: Testing a Unique Service Delivery Model in American Indian Head Start Programs
Brief Summary: An intensive intervention of specially trained paraprofessionals, called community oral health specialists (COHS), administering on a quarterly basis for 2 years fluoride varnish and oral health promotion education, compared to usual care, will reduce decayed, missing, and filled tooth surface measures at 2 years for children in American Indian Head Start Programs.


Options:
A: Intervention Type: DRUG; Name: Fluoride varnish; Assigned to Arm(s): N/A
B: Arm Label: COHS administered fluoride varnish and oral health education; Type: EXPERIMENTAL; Interventions: Device: Fluoride varnish, Behavioral: Oral health education | Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: Dental services delivered by the Indian Health Service. | Intervention Type: DEVICE; Name: Fluoride varnish; Assigned to Arm(s): COHS administered fluoride varnish and oral health education | Intervention Type: BEHAVIORAL; Name: Oral health education; Assigned to Arm(s): COHS administered fluoride varnish and oral health education | Intervention Type: OTHER; Name: Dental services delivered by the Indian Health Service.; Assigned to Arm(s): Usual care
C: Intervention Type: BEHAVIORAL; Name: Home Visiting; Assigned to Arm(s): N/A
D: Arm Label: Family Spirit Nurture (FSN); Type: EXPERIMENTAL; Interventions: Behavioral: Family Spirit Nurture (FSN), Other: Water Delivery | Arm Label: Control Program; Type: OTHER; Interventions: Other: Control Program, Other: Water Delivery | Intervention Type: BEHAVIORAL; Name: Family Spirit Nurture (FSN); Assigned to Arm(s): Family Spirit Nurture (FSN) | Intervention Type: OTHER; Name: Control Program; Assigned to Arm(s): Control Program | Intervention Type: OTHER; Name: Water Delivery; Assigned to Arm(s): Control Program, Family Spirit Nurture (FSN)

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Open-Label, Rollover Study to Evaluate the Long Term Safety and Efficacy of VX-770 in Subjects With Cystic Fibrosis
Brief Summary: The primary objective of the study was to evaluate the safety of long-term VX-770 treatment in participants with cystic fibrosis (CF). The secondary objective of the study was to evaluate the efficacy of long-term VX-770 treatment in subjects with CF.


Options:
A: Arm Label: VX-770; Type: EXPERIMENTAL; Interventions: Drug: Ivacaftor | Intervention Type: DRUG; Name: Ivacaftor; Assigned to Arm(s): VX-770
B: Arm Label: Ivacaftor; Type: EXPERIMENTAL; Interventions: Drug: Ivacaftor | Arm Label: Observational; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Ivacaftor; Assigned to Arm(s): Ivacaftor
C: Arm Label: Ivacaftor Group A; Type: EXPERIMENTAL; Interventions: Drug: Ivacaftor 25 mg/75 mg | Arm Label: Ivacaftor Group B; Type: EXPERIMENTAL; Interventions: Drug: Ivacaftor 75 mg/150 mg | Arm Label: Ivacaftor Group C; Type: EXPERIMENTAL; Interventions: Drug: Ivacaftor 150 mg or 250 mg | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Ivacaftor 25 mg/75 mg; Assigned to Arm(s): Ivacaftor Group A | Intervention Type: DRUG; Name: Ivacaftor 75 mg/150 mg; Assigned to Arm(s): Ivacaftor Group B | Intervention Type: DRUG; Name: Ivacaftor 150 mg or 250 mg; Assigned to Arm(s): Ivacaftor Group C | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Ivacaftor; Type: EXPERIMENTAL; Interventions: Drug: Ivacaftor | Intervention Type: DRUG; Name: Ivacaftor; Assigned to Arm(s): Ivacaftor

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Role of Renal Denervation in Improving Outcomes of Catheter Ablation in Patients With Refractory Symptomatic Atrial Fibrillation and Resistant Hypertension
Brief Summary: The purpose of this study is the comparative evaluation of systolic blood pressure (SBP) lowering, atrial fibrillation (AF) recurrence and clinical data in patients with paroxysmal/persistent AF and resistant hypertension, undergoing AF ablation alone or combined with percutaneous renal denervation.


Options:
A: Arm Label: Renal denervation; Type: EXPERIMENTAL; Interventions: Device: MDT-2211 Renal Denervation System | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: MDT-2211 Renal Denervation System; Assigned to Arm(s): Renal denervation
B: Arm Label: Renal sympathetic denervation; Type: EXPERIMENTAL; Interventions: Device: Renal sympathetic denervation (Symplicity ablation catheter, Medtronic Inc. Minneapolis, Minnesota, USA) | Arm Label: Sham procedure; Type: SHAM_COMPARATOR; Interventions: Other: Sham procedure | Intervention Type: DEVICE; Name: Renal sympathetic denervation (Symplicity ablation catheter, Medtronic Inc. Minneapolis, Minnesota, USA); Assigned to Arm(s): Renal sympathetic denervation | Intervention Type: OTHER; Name: Sham procedure; Assigned to Arm(s): Sham procedure
C: Arm Label: Renal Denervation; Type: EXPERIMENTAL; Interventions: Device: Renal Denervation (Symplicity® Renal Denervation System) | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Renal Denervation (Symplicity® Renal Denervation System); Assigned to Arm(s): Renal Denervation
D: Arm Label: Circumferential PVI; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Circumferential PV isolation | Arm Label: Circumferential PVI+renal denervation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Circumferential PVI+renal denervation | Intervention Type: PROCEDURE; Name: Circumferential PV isolation; Assigned to Arm(s): Circumferential PVI | Intervention Type: PROCEDURE; Name: Circumferential PVI+renal denervation; Assigned to Arm(s): Circumferential PVI+renal denervation

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Role of Renal Denervation in Improving Outcomes of Catheter Ablation in Patients With Refractory Symptomatic Atrial Fibrillation and Resistant Hypertension
Brief Summary: The purpose of this study is the comparative evaluation of systolic blood pressure (SBP) lowering, atrial fibrillation (AF) recurrence and clinical data in patients with paroxysmal/persistent AF and resistant hypertension, undergoing AF ablation alone or combined with percutaneous renal denervation.


Options:
A: Arm Label: Renal Denervation; Type: EXPERIMENTAL; Interventions: Device: Symplicity Spyral™ multi-electrode renal denervation system | Arm Label: Sham Procedure; Type: SHAM_COMPARATOR; Interventions: Procedure: Sham Procedure | Intervention Type: DEVICE; Name: Symplicity Spyral™ multi-electrode renal denervation system; Assigned to Arm(s): Renal Denervation | Intervention Type: PROCEDURE; Name: Sham Procedure; Assigned to Arm(s): Sham Procedure
B: Arm Label: Circumferential PVI; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Circumferential PV isolation | Arm Label: Circumferential PVI+renal denervation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Circumferential PVI+renal denervation | Intervention Type: PROCEDURE; Name: Circumferential PV isolation; Assigned to Arm(s): Circumferential PVI | Intervention Type: PROCEDURE; Name: Circumferential PVI+renal denervation; Assigned to Arm(s): Circumferential PVI+renal denervation
C: Arm Label: Ultrasound Renal Denervation; Type: EXPERIMENTAL; Interventions: Device: The Paradise® Renal Denervation Ultrasound System | Arm Label: Sham Procedure; Type: SHAM_COMPARATOR; Interventions: Device: Sham Procedure | Intervention Type: DEVICE; Name: The Paradise® Renal Denervation Ultrasound System; Assigned to Arm(s): Ultrasound Renal Denervation | Intervention Type: DEVICE; Name: Sham Procedure; Assigned to Arm(s): Sham Procedure
D: Arm Label: Renal denervation; Type: EXPERIMENTAL; Interventions: Device: MDT-2211 Renal Denervation System | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: MDT-2211 Renal Denervation System; Assigned to Arm(s): Renal denervation

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Apathy in Dementia Methylphenidate Trial (ADMET)
Brief Summary: The Apathy in Dementia Methylphenidate Trial (ADMET) is a masked, placebo-controlled trial that will examine the efficacy and safety of methylphenidate for the treatment of clinically significant apathy in patients with Alzheimer's dementia.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Valproate | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Valproate; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
B: Arm Label: Methylphenidate; Type: EXPERIMENTAL; Interventions: Drug: Methylphenidate, Other: Psychosocial intervention | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo, Other: Psychosocial intervention | Intervention Type: DRUG; Name: Methylphenidate; Assigned to Arm(s): Methylphenidate | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo | Intervention Type: OTHER; Name: Psychosocial intervention; Assigned to Arm(s): Methylphenidate, Placebo
C: Arm Label: Cholinesterase inhibitor only; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Cholinesterase Plus Modafinil; Type: EXPERIMENTAL; Interventions: Drug: Modafinil | Intervention Type: DRUG; Name: Modafinil; Assigned to Arm(s): Cholinesterase Plus Modafinil | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Cholinesterase inhibitor only
D: Intervention Type: DRUG; Name: Olanzapine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Quetiapine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Risperidone; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Citalopram; Assigned to Arm(s): N/A

Answer: B